Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
01 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
02 Executive Summary
03 Intravenous Solution Market Overview
3.1 Latin America Intravenous Solution Market Overview
3.1.1 Latin America Intravenous Solution Market Historical Value (2019-2025)
3.1.2 Latin America Intravenous Solution Market Forecast Value (2026-2035)
3.2 Mexico Intravenous Solution Market Overview
3.2.1 Mexico Intravenous Solution Market Historical Value (2019-2025)
3.2.2 Mexico Intravenous Solution Market Forecast Value (2026-2035)
04 Mexico Intravenous Solution Market Landscape
4.1 Mexico Intravenous Solution Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Mexico Intravenous Solution Market: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Bag Type
4.2.3 Analysis by Nutrients
05 Mexico Intravenous Solution Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter’s Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
06 Mexico Intravenous Solution Market Segmentation (2019-2035)
6.1 Mexico Intravenous Solution Market (2019-2035) by Type
6.1.1 Partial Parenteral Nutrition
6.1.2 Total Parenteral Nutrition
6.2 Mexico Intravenous Solution Market (2019-2035) by Nutrients
6.2.1 Carbohydrates
6.2.2 Salts and Electrolytes
6.2.3 Minerals and Vitamins
6.2.4 Amino Acids
6.2.5 Others
6.3 Mexico Intravenous Solution Market (2019-2035) by Bag Type
6.3.1 Large Volume Bags (>250 mL)
6.3.2 Small Volume Bags (<250 mL)
6.4 Mexico Intravenous Solution Market (2019-2035) by Application
6.4.1 Basic IV Solution
6.4.2 Nutritional IV Solution
6.4.3 Blood IV Solution
6.4.4 Drug IV Solution
6.4.5 Irrigation IV Solution
6.4.6 Others
6.5 Mexico Intravenous Solution Market (2019-2035) by End User
6.5.1 Hospitals and Clincs
6.5.2 Ambulatory Surgical Centers (ASCs)
6.5.3 Homecare Settings
6.5.4 Others
07 Regulatory Framework
08 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
09 Strategic Initiatives
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Initiatives
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Supplier Landscape
10.1 Vendor Positioning Analysis
10.1.1 Key Vendors
10.1.2 Prospective Leaders
10.1.3 Niche Leaders
10.1.4 Disruptors
10.2 Market Share Analysis (Top 5 Companies)
10.3 Ajinomoto Health & Nutrition North America, Inc.
10.3.1 Financial Analysis
10.3.2 Product Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Company News and Development
10.3.5 Certifications
10.4 B. Braun SE
10.4.1 Financial Analysis
10.4.2 Product Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Company News and Development
10.4.5 Certifications
10.5 ICU Medical, Inc.
10.5.1 Financial Analysis
10.5.2 Product Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Company News and Development
10.5.5 Certifications
10.6 Baxter AG
10.6.1 Financial Analysis
10.6.2 Product Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Company News and Development
10.6.5 Certifications
10.7 Fresenius Kabi AG
10.7.1 Financial Analysis
10.7.2 Product Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Company News and Development
10.7.5 Certifications
10.8 Pfizer Inc.
10.8.1 Financial Analysis
10.8.2 Product Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Company News and Development
10.8.5 Certifications
10.9 Otsuka Pharmaceutical Co., Ltd.
10.9.1 Financial Analysis
10.9.2 Product Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Company News and Development
10.9.5 Certifications
10.10 Vifor Pharma Management Ltd.
10.10.1 Financial Analysis
10.10.2 Product Portfolio
10.10.3 Demographic Reach and Achievements
10.10.4 Company News and Development
10.10.5 Certifications
11 Mexico Intravenous Solution Market – Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
12 Key Opinion Leaders (KOL) Insights (Additional Insight)